611-620 of 2966 Results Found
CME Session
PCH - Phoenix Children's Grand Rounds - Hold the Toast!! Ketogenic Therapies for Epilepsy and Beyond - Randa Jarrar, MD, Christi Wheeler, RD, and Lisa Vanetta, RD
At the end of this presentation, participants should be able to: 1. Understand the macronutrient breakdown of ketogenic therapies, potential mechanisms of action, and efficacy in seizure management. 2. Recognize and effectively manage common side effects of ketogenic therapy. 3
Doctor
Renee J. Crawford, DO
Specialties
- Ambulatory Pediatrics
- Emergency Medicine
- Hospital Medicine
- Urgent Care
Article
Phoenix Children’s Promotes Mike Meekins to Senior Vice President of Operations
Meekins will advance operational leadership to better serve children and families across the region
Doctor
Lisa E. McMahon, MD
Medical Director, Pectus Center; Surgical Director, Inflammatory Bowel Disease Program
Specialties
Article
Phoenix Children’s Promotes Chad Johnson to Oversee Medical Group Administrative Operations
Phoenix Children’s promotes Chad Johnson, Senior Vice President of Phoenix Children’s Care Network, to assume an expanded role with the health system, providing oversight for Phoenix Children’s Medical Group administrative operations.
CME Session
VWGR | PCH - Quality Day 2024: Using Quality Improvement Methods to Improve Patient Care for Children with Cleft Lip and Palate - Thomas Sitzman, MD
… Using Quality Improvement Methods to Improve Patient Care for Children with Cleft Lip and Palate - Thomas Sitzman, MD … Passcode: 762046 Contact Megan Jehlicka to claim CME credit for this session: megan_jehlicka [at] dmgaz.org ( …
Article
Phoenix Children’s Earns National Recognition as a Pediatric Pulmonary Hypertension Network Site
Phoenix Children’s has been designated a network site member of the Pediatric Pulmonary Hypertension Network (PPHNet).
Gastroenterology Research
Research in gastroenterology, hepatology and nutrition at Phoenix Children’s is helping advance our understanding of gastrointestinal (GI) and liver diseases. Through these studies, we are making strides in improving therapies for children affected by these conditions. At Phoenix
